181 results
Page 8 of 10
6-K
EX-99.1
8usq0m85ab62 8kxgwq
24 Jul 18
Acasti Pharma Awarded Composition-of-Matter Patent by the U.S. Patent and Trademark Office
7:00am
6-K
EX-99.1
jbkabmt
2 Jul 18
Current report (foreign)
5:14pm
6-K
EX-99.1
lgj0or1c rzi
27 Jun 18
Current report (foreign)
5:27pm
6-K
EX-99.1
5z712jl
27 Jun 18
Acasti Pharma Business Update for the Fourth Quarter and Fiscal 2018
5:01pm
6-K
EX-99.1
ysp1rw 5sl9jg9bw
6 Jun 18
Acasti Pharma to Present at the XVIII(th) International Symposium on Atherosclerosis
7:00am
6-K
EX-99.1
56aplbjz2pjsf5 c8
5 Jun 18
Acasti Pharma Appoints Brian Groch as Chief Commercial Officer
12:00am
6-K
EX-99.1
u6hc 0oda4
18 May 18
Current report (foreign)
8:44am
6-K
EX-99.1
blzbpw2 zn
14 May 18
Acasti Pharma Announces Full Exercise of Over-Allotment Option
2:32pm
6-K
EX-99.1
egka0c96 h08
9 May 18
Acasti Pharma Announces Closing of $10 Million Underwritten Offering
5:17pm
6-K
EX-99.1
u5wal6tbxdrjpkp8k5t
27 Apr 18
Acasti Pharma Appoints Donald Olds to its Board of Directors and Audit Committee
8:00am
6-K
EX-99.1
q5vrid87t ll37
22 Jan 18
Acasti Pharma Announces the Closing of Over-Allotment
12:00am
6-K
EX-99.1
oya1x5n
27 Dec 17
Acasti Pharma Announces Closing of US$10 Million Firm Commitment Offering of Common Shares and Warrants
12:00am
6-K
EX-99.1
i2ec3o0jv70xl7c9q
24 Apr 17
Acasti Pharma Inc. 6-K
12:00am
6-K
EX-99.1
q41akq1
26 Oct 16
Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre
12:00am
6-K
EX-99.1
0v3rx7 wjtsuij
14 Oct 15
Current report (foreign)
12:00am
6-K
EX-99.1
0vn0zcehv8so7az8owod
13 Jan 15
Current report (foreign)
12:00am